AstraZeneca will seek regulatory approval for an antibody drug after a study showed strong efficacy in preventing symptomatic Covid-19
LONDON— AstraZeneca PLC said Friday it would seek regulatory approval for an antibody drug after a study showed strong efficacy in preventing symptomatic Covid-19, offering a potential new alternative to vaccines for people who refuse shots or for whom they aren’t effective.
The development comes as drug companies look to roll out antibody drugs as additional tools to stem pandemic hospitalizations and deaths. While multiple Covid-19 vaccines were invented, tested and rolled out at unusually fast speeds, the development of antibody treatments and other reliable therapeutics
, with more mixed results. But recently, antibody treatments have raised hopes as valuable tools to battle severe cases and reduce deaths.to prevent hospitals from being overwhelmed as the highly transmissible Delta variant spreads. Monoclonal antibody drugs are designed to mimic natural antibodies produced by the immune system to fight the coronavirus.
Separately, the U.K. on Friday approved the first monoclonal-antibody treatment for use in the country, a combination from Regeneron Pharmaceuticals Inc. and Roche Holding AG .Britain’s adoption of the Regeneron-Roche antibody combination, called Ronapreve in the U.K., means it can be used to treat acute Covid-19 symptoms and stem infection, ideally keeping people from needing hospitalization, according to the country’s medicines regulator and health officials.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid-19 antibody treatments work, but they're 'not the path out of this pandemic'When Texas Gov. Greg Abbott announced Tuesday that had tested postiive for Covid-19, his office shared that he was treated with a therapy not yet approved by the US Food and Drug Administration, but one of the few shown to be effective against the virus: monoclonal antibodies.
Weiterlesen »
Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.
Weiterlesen »
Pfizer’s Covid-19 Booster Shot Improves Immunity, Israeli Study SuggestsEarly data from Israel suggests a booster shot of Pfizer's Covid-19 vaccine can significantly improve immunity in those aged 60 and above, as other countries plan additional doses to increase protection against the highly infectious Delta variant
Weiterlesen »
Sonny Chiba, martial arts star of 'Kill Bill,' dies of Covid-19 complicationsCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Weiterlesen »
Lacking Beds, Hospitals Ship COVID-19 Patients to Other StatesHospitals in several states are full of COVID-19 patients and no longer have beds available, so they’re sending patients to other states for treatment -- sometimes hundreds of miles away in ambulances, helicopters, and planes.
Weiterlesen »